A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
New England Journal of Medicine · 05.02.2026 · 394 (6) · 529-539
DOI: 10.1056/nejmoa2511002 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 05.02.2026. Verfasst von Ann Marie Navar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Atherosclerosis, Cardiovascular Diseases, Cholesterol, LDL, Hypercholesterolemia. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Merck Sharp and Dohme LLC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas.
- MSD UK, London.
- University of Milan, Milan.
- IRCCS Multimedica, Milan.
- MSD, Rahway, NJ.
- University of Cape Town, Cape Town, South Africa.
Förderung
- Merck Sharp and Dohme LLC
Zitieren
APA
Navar, A. M., Mikhailova, E., Catapano, A. L., Banka, P., Blom, D. J., Cadena, A., Kourpanidis, S., Lepor, N. E., Tsukamoto, K., Mendizabal, G., Nunez, J., Zhang, W., Zhu, P., Zhuo, M., Ballantyne, C. M., & CORALreef Lipids Investigators (2026). A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine, 394(6), 529-539. https://doi.org/10.1056/nejmoa2511002
Vancouver
Navar AM, Mikhailova E, Catapano AL, Banka P, Blom DJ, Cadena A, et al. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine. 2026;394(6):529-539. doi:10.1056/nejmoa2511002
BibTeX
@article{Navar2026,
author = {Navar, Ann Marie and Mikhailova, Elina and Catapano, Alberico L and Banka, Puja and Blom, Dirk J and Cadena, Alberto and Kourpanidis, Susan and Lepor, Norman E and Tsukamoto, Kazuhisa and Mendizabal, Geraldine and Nunez, Julio and Zhang, Wenjuan and Zhu, Pengfei and Zhuo, Min and Ballantyne, Christie M and CORALreef Lipids Investigators, CORALreef Lipids Investigators},
title = {A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {6},
pages = {529--539},
doi = {10.1056/nejmoa2511002}
}
EUVIMED